Inventor · disambiguated record
Johannes Joseph Wilhelmus De Haard
Also filed as: DE HAARD JOHANNES · DE HAARD JOHANNES J W · DE HAARD JOHANNES JOSEPH · DE HAARD JOHANNES JOSEPH WILHE
50 granted patents·29 pending applications·391 citations·filing 2001–2025
98Inventor score
Top patents by PatentIndex Score
79 records- 0195US8907065B2Polypeptides that modulate the interaction between cells of the immune systemHERMANS GUY·Filed 2007·Granted Dec 9, 2014·49 cites·34 claims
- 0294US9765149B2Antibodies to CD70ARGEN-X N V·Filed 2014·Granted Sep 19, 2017·24 cites·22 claims
- 0394US9765148B2Antibodies to CD70SILENCE KAREN·Filed 2012·Granted Sep 19, 2017·32 cites·13 claims
- 0494US8834882B2Antibodies to CD70SILENCE KAREN·Filed 2013·Granted Sep 16, 2014·30 cites·12 claims
- 0593US9315576B2Antigen binding polypeptidesARGEN X BV·Filed 2015·Granted Apr 19, 2016·5 cites·12 claims
- 0693US8557965B2Single variable domains against notch pathway membersSAUNDERS MICHAEL JOHN SCOTT·Filed 2009·Granted Oct 15, 2013·45 cites·13 claims
- 0793US8524231B2Antigen binding polypeptidesDREIER TORSTEN·Filed 2011·Granted Sep 3, 2013·19 cites·32 claims
- 0893US8444976B2Antigen binding polypeptidesDREIER TORSTEN·Filed 2009·Granted May 21, 2013·12 cites·19 claims
- 0992US11505585B2FcRn antagonists and methods of useargenx BV·Filed 2017·Granted Nov 22, 2022·7 cites·10 claims
- 1092US10316073B2FCRN antagonists and methods of useARGENX BVBA·Filed 2014·Granted Jun 11, 2019·20 cites·10 claims
- 1192US9221918B2Antigen binding polypeptidesARGEN X BV·Filed 2015·Granted Dec 29, 2015·5 cites·4 claims
- 1291US9540437B2Humanized antibodiesARGEN-X N V·Filed 2014·Granted Jan 10, 2017·8 cites·49 claims
- 1391US9346891B2Antigen binding polypeptidesARGEN X BV·Filed 2015·Granted May 24, 2016·5 cites·20 claims
- 1490US12344678B2FcRn/HSA binding molecules and methods of useargenx BV·Filed 2024·Granted Jul 1, 2025·3 cites·14 claims
- 1590US9428580B2Antigen binding polypeptidesDREIER TORSTEN·Filed 2011·Granted Aug 30, 2016·5 cites·28 claims
- 1690US9193780B2Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseasesHULTBERG ANNA·Filed 2009·Granted Nov 24, 2015·21 cites·19 claims
- 1789US9631027B2Anti c-Met antibodiesARGEN-X N V·Filed 2015·Granted Apr 25, 2017·7 cites·25 claims
- 1889US9005963B2Amino acid sequences directed against cellular receptors for viruses and bacteriaBLANCHETOT CHRISTOPHE·Filed 2009·Granted Apr 14, 2015·13 cites·18 claims
- 1989US8906680B2Amino acid sequences directed against chemokines and polypeptides comprising the same for the treatment of chemokine-related diseases and disordersBLANCHETOT CHRISTOPHE·Filed 2007·Granted Dec 9, 2014·11 cites·34 claims
- 2089US8637027B2Anti c-Met antibodiesHULTBERG ANNA·Filed 2011·Granted Jan 28, 2014·12 cites·21 claims
- 2188US12240875B2Use of FCRN antagonists for treatment of generalized myasthenia gravisargenx BV·Filed 2018·Granted Mar 4, 2025·3 cites·21 claims
- 2285US11712468B2CD70 combination therapyargenx BV·Filed 2019·Granted Aug 1, 2023·3 cites·36 claims
- 2385US9926364B2Chimeric human-llama antigens and methods of useARGEN X N V·Filed 2012·Granted Mar 27, 2018·5 cites·18 claims
- 2483US11434298B2Antibodies to CD70argenx BV·Filed 2019·Granted Sep 6, 2022·1 cites·11 claims
- 2583US11072665B2Antibodies to CD70ARGENX BVBA·Filed 2015·Granted Jul 27, 2021·2 cites·39 claims
- 2683US9688773B2C-Met antibody combinationsHULTBERG ANNA·Filed 2011·Granted Jun 27, 2017·5 cites·20 claims
- 2782US9884917B2Anti c-Met antibodiesARGEN X N V·Filed 2013·Granted Feb 6, 2018·4 cites·9 claims
- 2882US9156914B2Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disordersBLANCHETOT CHRISTOPHE·Filed 2007·Granted Oct 13, 2015·4 cites·10 claims
- 2981US2024158492A1Il-6 binding moleculesargenx BV·Filed 2023·Application pending·0 cites
- 3081US2023265201A1Antibodies to cd70argenx BV·Filed 2022·Application pending·0 cites
- 3180US9803018B2Amino acid sequences directed against cellular receptors for viruses and bacteriaABLYNX NV·Filed 2015·Granted Oct 31, 2017·2 cites·14 claims
- 3280US9212226B2Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the sameBLANCHETOT CHRISTOPHE·Filed 2009·Granted Dec 15, 2015·5 cites·12 claims
- 3379US10696741B2Anti-IL-22R antibodiesARGENX BVBA·Filed 2019·Granted Jun 30, 2020·1 cites·23 claims
- 3479US10040870B2Highly diverse combinatorial antibody librariesARGENX BVBA·Filed 2013·Granted Aug 7, 2018·5 cites·4 claims
- 3579US9382333B2Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesisABLYNX NV·Filed 2014·Granted Jul 5, 2016·3 cites·11 claims
- 3679US8835607B2Humanized antibodiesDREIER TORTEN·Filed 2011·Granted Sep 16, 2014·8 cites·33 claims
- 3775US11827701B2IL-6 binding moleculesargenx BV·Filed 2021·Granted Nov 28, 2023·0 cites·18 claims
- 3875US10183995B2IL-6 binding moleculesARGEN X N V·Filed 2013·Granted Jan 22, 2019·2 cites·36 claims
- 3975US2023088269A1Anti-il-22r antibodiesARGENX BVBA·Filed 2022·Application pending·0 cites
- 4075US2025059262A1Method of preparing ph-dependent antibodiesargenx BV·Filed 2024·Application pending·0 cites
- 4173US9688774B2Anti c-Met antibodiesARGEN-X N V·Filed 2015·Granted Jun 27, 2017·1 cites·24 claims
- 4272US11117959B2IL-6 binding moleculesARGENX BVBA·Filed 2019·Granted Sep 14, 2021·0 cites·15 claims
- 4372US10487156B2Asymmetric multispecific antibodiesARGENX BVBA·Filed 2015·Granted Nov 26, 2019·1 cites·6 claims
- 4471US8858940B2Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesisGONZALEZ PAJUELO MARIA·Filed 2009·Granted Oct 14, 2014·2 cites·11 claims
- 4571US2024033353A1Cd70 combination therapyargenx BV·Filed 2023·Application pending·0 cites
- 4671US2025382388A1Fcrn/hsa binding molecules and methods of useargenx BV·Filed 2025·Application pending·0 cites
- 4770US2025122288A1Fcrn binding molecules and methods of useargenx BV·Filed 2024·Application pending·0 cites
- 4870US2022275035A1Fcrn antagonists and methods of useargenx BV·Filed 2022·Application pending·0 cites
- 4969US11447544B2Anti-IL-22R antibodiesargenx BV·Filed 2019·Granted Sep 20, 2022·0 cites·26 claims
- 5069US11261246B2Anti-IL-22R antibodiesARGENX BVBA·Filed 2019·Granted Mar 1, 2022·0 cites·23 claims
Showing the top 50 of 79 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →